Showing results (331-340 of 620) with videos related to
Sort By:
Pageof 62
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1992
CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activationY Torimoto, D M Rothstein, N H Dang, et al.European Journal of Biochemistry|May 15, 1995
Immunoelectron microscopy and epitope mapping with monoclonal antibodies suggest the existence of an additional N-terminal transmembrane helix in the cytochrome b subunit of bacterial ubiquinol:cytochrome-c oxidoreductasesG Kleymann, S Iwata, K H Wiesmüller, et al.Acta Crystallographica. Section D, Biological Crystallography|August 16, 2000
Purification, crystallization and preliminary crystallographic studies of an integral membrane protein, cytochrome bo3 ubiquinol oxidase from Escherichia coliJ Abramson, G Larsson, B Byrne, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1992
CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functionsK Sugita, T Hirose, D M Rothstein, et al.European Journal of Immunology|February 1, 1991
Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture systemA Yamada, Y Nojima, K Sugita, et al.British Journal of Cancer|August 6, 2009
CD26 expression on T cell lines increases SDF-1-alpha-mediated invasionP A Havre, M Abe, Y Urasaki, et al.Immunology|October 1, 1993
Protein kinase A-mediated phosphorylation of the T-cell surface antigen CD27K Sugita, J D Dasgupta, Y Nojima, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1991
Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytesY Torimoto, N H Dang, E Vivier, et al.Transplantation|May 27, 1994
The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantationK Sugita, R J Soiffer, C Murray, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1988
Human T cells can be directed to lyse tumor targets through the alternative activation/T11-E rosette receptor pathwayC F Scott, J M Lambert, R S Kalish, et al.Pageof 62